Clinical Trials › NCT07337785
RecruitingPhase 1
CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases
Sponsored by Daishi Tian
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 36
Target enrollment
Dec 2025
Start date
Nov 2028
Expected completion
Interventions / Treatments
CD19/BCMA-targeted CAR-T cellsLymphodepleting Conditioning
Conditions studied
Relapsing or Refractory Multiple Sclerosis (MS)
Trial locations
U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.
More Phase 1 trials
Browse all Phase 1 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.